GlassScriptPhysician profile
Omar M Rashid
NPI 1952833881
$5,115.01
in general payments reported to CMS, 2019-2025
36 companies · $1,440 in 2025
The $1,440 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $590 · 2023: $1,017 · 2024: $1,734 · 2025: $1,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,154 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,153.56 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $786.73 | 2023-2025 | |
| Viiv Healthcare Company | $780.17 | 2022-2025 | Apretude, Cabenuva |
| Abbvie INC. | $661.14 | 2021-2025 | |
| Lilly USA, LLC | $578.65 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Gilead Sciences, INC. | $369.11 | 2021-2025 | |
| Novo Nordisk INC | $212.10 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $195.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Inspire Medical Systems, INC. | $180.86 | 2024 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $132.83 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $119.98 | 2024-2025 | Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $113.92 | 2021-2025 | Trintellix |
| Glaxosmithkline, LLC. | $97.19 | 2023-2024 | Trelegy Ellipta |
| Lucid Diagnostics INC. | $90.14 | 2022 | |
| Astellas Pharma US INC | $73.48 | 2023-2025 | Veozah |
| Amgen INC. | $72.58 | 2021-2024 | Evenity, Prolia |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Rashid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.